Virpax Pharmaceuticals, Inc. (VRPX)

NASDAQ: VRPX · IEX Real-Time Price · USD

0.530

+0.029 (5.81%)

At close: Jul 2, 2024, 4:00 PM

0.524

-0.006 (-1.15%)

After-hours: Jul 2, 2024, 6:50 PM EDT

Virpax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	9.14	19	36.84	0.05	0.04	Upgrade
Cash & Cash Equivalents	9.14	19	36.84	0.05	0.04	Upgrade
Cash Growth	-51.87%	-48.44%	67134.82%	31.92%	-14.13%	Upgrade
Other Current Assets	0.49	0.68	2.73	0.02	0.01	Upgrade
Total Current Assets	9.63	19.67	39.57	0.07	0.05	Upgrade
Other Long-Term Assets	0	0	0	0.39	0	Upgrade
Total Long-Term Assets	0	0	0	0.39	0	Upgrade
Total Assets	9.63	19.67	39.57	0.47	0.05	Upgrade
Accounts Payable	1.69	1.09	2.09	3.12	1.51	Upgrade
Current Debt	0	0	0	0.54	1.26	Upgrade
Other Current Liabilities	6	2	0	0	0	Upgrade
Total Current Liabilities	7.69	3.09	2.09	3.66	2.78	Upgrade
Long-Term Debt	0	0	0	1.02	0	Upgrade
Total Long-Term Liabilities	0	0	0	1.02	0	Upgrade
Total Liabilities	7.69	3.09	2.09	4.68	2.78	Upgrade
Total Debt	0	0	0	1.57	1.26	Upgrade
Debt Growth	-	-	-	23.81%	152.90%	Upgrade
Retained Earnings	-59.54	-44.35	-22.7	-10.65	-6.31	Upgrade
Shareholders' Equity	1.93	16.58	37.48	-4.22	-2.73	Upgrade
Net Cash / Debt	9.14	19	36.84	-1.51	-1.22	Upgrade
Net Cash / Debt Growth	-51.87%	-48.44%	-	-	-	Upgrade
Net Cash Per Share	7.81	16.22	55.18	-4.86	-4.18	Upgrade
Working Capital	1.93	16.58	37.48	-3.59	-2.73	Upgrade
Book Value Per Share	1.65	14.16	56.14	-13.57	-9.33	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).